BiVictriX Therapeutics PLC (GB:BVX)
LSE:BVX
Holding GB:BVX?
Track your performance easily

BiVictriX Therapeutics PLC (BVX) Financial Statements

0 Followers

BiVictriX Therapeutics PLC Financial Overview

BiVictriX Therapeutics PLC's market cap is currently ―. The company's EPS TTM is p-0.035; its P/E ratio is -2.93; BiVictriX Therapeutics PLC is scheduled to report earnings on March 10, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 3.29M£ 4.55M£ 6.06M£ 376.00K£ 862.00K
Total Assets£ 4.54M£ 5.75M£ 6.88M£ 660.00K£ 1.07M
Total Debt£ 295.00K£ 246.00K£ 246.00K£ 0.00£ 671.00K
Net Debt£ -2.99M£ -4.30M£ -5.82M£ -376.00K£ -191.00K
Total Liabilities£ 579.00K£ 700.00K£ 554.00K£ 1.01M£ 1.00M
Stockholders Equity£ 3.96M£ 5.05M£ 6.33M£ -348.00K£ 67.00K
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

BiVictriX Therapeutics PLC Earnings and Revenue History

BiVictriX Therapeutics PLC Debt to Assets

BiVictriX Therapeutics PLC Cash Flow

BiVictriX Therapeutics PLC Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis